OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 874
Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 874
Showing 1-25 of 874 citing articles:
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
James M. Sanders, Marguerite L. Monogue, Tomasz Z. Jodlowski, et al.
JAMA (2020)
Closed Access | Times Cited: 2398
James M. Sanders, Marguerite L. Monogue, Tomasz Z. Jodlowski, et al.
JAMA (2020)
Closed Access | Times Cited: 2398
COVID-19 pathophysiology: A review
Koichi Yuki, Miho Fujiogi, Sophia Koutsogiannaki
Clinical Immunology (2020) Vol. 215, pp. 108427-108427
Open Access | Times Cited: 2137
Koichi Yuki, Miho Fujiogi, Sophia Koutsogiannaki
Clinical Immunology (2020) Vol. 215, pp. 108427-108427
Open Access | Times Cited: 2137
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Melika Lotfi, Michael R. Hamblin, Nima Rezaei
Clinica Chimica Acta (2020) Vol. 508, pp. 254-266
Open Access | Times Cited: 987
Melika Lotfi, Michael R. Hamblin, Nima Rezaei
Clinica Chimica Acta (2020) Vol. 508, pp. 254-266
Open Access | Times Cited: 987
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2657-2657
Open Access | Times Cited: 708
Yung-Fang Tu, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2657-2657
Open Access | Times Cited: 708
COVID-19: Immunology and treatment options
Susanna Felsenstein, Jenny A. Herbert, Paul McNamara, et al.
Clinical Immunology (2020) Vol. 215, pp. 108448-108448
Open Access | Times Cited: 657
Susanna Felsenstein, Jenny A. Herbert, Paul McNamara, et al.
Clinical Immunology (2020) Vol. 215, pp. 108448-108448
Open Access | Times Cited: 657
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention
Anshika Sharma, Isra Ahmad Farouk, Sunil K. Lal
Viruses (2021) Vol. 13, Iss. 2, pp. 202-202
Open Access | Times Cited: 598
Anshika Sharma, Isra Ahmad Farouk, Sunil K. Lal
Viruses (2021) Vol. 13, Iss. 2, pp. 202-202
Open Access | Times Cited: 598
Cytokine storm induced by SARS-CoV-2
Peipei Song, Wei Li, Jianqin Xie, et al.
Clinica Chimica Acta (2020) Vol. 509, pp. 280-287
Open Access | Times Cited: 536
Peipei Song, Wei Li, Jianqin Xie, et al.
Clinica Chimica Acta (2020) Vol. 509, pp. 280-287
Open Access | Times Cited: 536
Clinical management of COVID-19
George M. Varghese, Rebecca John, Abi Manesh, et al.
The Indian Journal of Medical Research (2020) Vol. 151, Iss. 5, pp. 401-401
Open Access | Times Cited: 503
George M. Varghese, Rebecca John, Abi Manesh, et al.
The Indian Journal of Medical Research (2020) Vol. 151, Iss. 5, pp. 401-401
Open Access | Times Cited: 503
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Ioannis Zabetakis, Ronan Lordan, Catherine Norton, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1466-1466
Open Access | Times Cited: 500
Ioannis Zabetakis, Ronan Lordan, Catherine Norton, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1466-1466
Open Access | Times Cited: 500
Convalescent plasma in Covid-19: Possible mechanisms of action
Manuel Rojas, Yhojan Rodríguez, Diana M. Monsalve, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102554-102554
Open Access | Times Cited: 492
Manuel Rojas, Yhojan Rodríguez, Diana M. Monsalve, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102554-102554
Open Access | Times Cited: 492
The hallmarks of COVID-19 disease
Daolin Tang, Paul B. Comish, Rui Kang
PLoS Pathogens (2020) Vol. 16, Iss. 5, pp. e1008536-e1008536
Open Access | Times Cited: 449
Daolin Tang, Paul B. Comish, Rui Kang
PLoS Pathogens (2020) Vol. 16, Iss. 5, pp. e1008536-e1008536
Open Access | Times Cited: 449
Coronavirus Disease (COVID-19): A primer for emergency physicians
Summer Chavez, Brit Long, Alex Koyfman, et al.
The American Journal of Emergency Medicine (2020) Vol. 44, pp. 220-229
Open Access | Times Cited: 308
Summer Chavez, Brit Long, Alex Koyfman, et al.
The American Journal of Emergency Medicine (2020) Vol. 44, pp. 220-229
Open Access | Times Cited: 308
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
Mohammed Uddin, Farah Mustafa, Tahir A. Rizvi, et al.
Viruses (2020) Vol. 12, Iss. 5, pp. 526-526
Open Access | Times Cited: 292
Mohammed Uddin, Farah Mustafa, Tahir A. Rizvi, et al.
Viruses (2020) Vol. 12, Iss. 5, pp. 526-526
Open Access | Times Cited: 292
Current status of potential therapeutic candidates for the COVID-19 crisis
Jiancheng Zhang, Bing Xie, Kenji Hashimoto
Brain Behavior and Immunity (2020) Vol. 87, pp. 59-73
Open Access | Times Cited: 287
Jiancheng Zhang, Bing Xie, Kenji Hashimoto
Brain Behavior and Immunity (2020) Vol. 87, pp. 59-73
Open Access | Times Cited: 287
The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
Lo’ai Alanagreh, Foad Alzoughool, Manar Atoum
Pathogens (2020) Vol. 9, Iss. 5, pp. 331-331
Open Access | Times Cited: 278
Lo’ai Alanagreh, Foad Alzoughool, Manar Atoum
Pathogens (2020) Vol. 9, Iss. 5, pp. 331-331
Open Access | Times Cited: 278
What dentists need to know about COVID-19
Maryam Baghizadeh Fini
Oral Oncology (2020) Vol. 105, pp. 104741-104741
Open Access | Times Cited: 246
Maryam Baghizadeh Fini
Oral Oncology (2020) Vol. 105, pp. 104741-104741
Open Access | Times Cited: 246
COVID-19 in older people: a rapid clinical review
Fiona E. Lithander, Sandra Neumann, Emma Tenison, et al.
Age and Ageing (2020) Vol. 49, Iss. 4, pp. 501-515
Open Access | Times Cited: 245
Fiona E. Lithander, Sandra Neumann, Emma Tenison, et al.
Age and Ageing (2020) Vol. 49, Iss. 4, pp. 501-515
Open Access | Times Cited: 245
Coagulation and anticoagulation in COVID-19
Tarik Hadid, Zyad Kafri, Ayad Al-Katib
Blood Reviews (2020) Vol. 47, pp. 100761-100761
Open Access | Times Cited: 212
Tarik Hadid, Zyad Kafri, Ayad Al-Katib
Blood Reviews (2020) Vol. 47, pp. 100761-100761
Open Access | Times Cited: 212
COVID-19: Present and Future Challenges for Dental Practice
Najla Dar‐Odeh, Hamzah Babkair, Shaden Abu‐Hammad, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 9, pp. 3151-3151
Open Access | Times Cited: 209
Najla Dar‐Odeh, Hamzah Babkair, Shaden Abu‐Hammad, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 9, pp. 3151-3151
Open Access | Times Cited: 209
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 4
Open Access | Times Cited: 208
Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 4
Open Access | Times Cited: 208
Long COVID and its Management
Ho Cheng Koc, Jing Xiao, Weiwei Liu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4768-4780
Open Access | Times Cited: 202
Ho Cheng Koc, Jing Xiao, Weiwei Liu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4768-4780
Open Access | Times Cited: 202
Application of Artificial Intelligence in COVID-19 drug repurposing
Sweta Mohanty, Md Harun AI Rashid, Mayank Mridul, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 5, pp. 1027-1031
Open Access | Times Cited: 180
Sweta Mohanty, Md Harun AI Rashid, Mayank Mridul, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 5, pp. 1027-1031
Open Access | Times Cited: 180
Rethinking the role of hydroxychloroquine in the treatment of COVID‐19
Eric A. Meyerowitz, Augustin Vannier, Morgan G. N. Friesen, et al.
The FASEB Journal (2020) Vol. 34, Iss. 5, pp. 6027-6037
Open Access | Times Cited: 177
Eric A. Meyerowitz, Augustin Vannier, Morgan G. N. Friesen, et al.
The FASEB Journal (2020) Vol. 34, Iss. 5, pp. 6027-6037
Open Access | Times Cited: 177
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100719-100719
Open Access | Times Cited: 170
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100719-100719
Open Access | Times Cited: 170
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Eugenia Quirós-Roldán, Giorgio Biasiotto, Paola Magro, et al.
Pharmacological Research (2020) Vol. 158, pp. 104904-104904
Open Access | Times Cited: 156
Eugenia Quirós-Roldán, Giorgio Biasiotto, Paola Magro, et al.
Pharmacological Research (2020) Vol. 158, pp. 104904-104904
Open Access | Times Cited: 156
